Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite

Researchers including one of an Indian origin have suggested that when there are high financial incentives to succeed, people can become so afraid of losing their potentially lucrative reward that